FDA Advisory Panel Member Abraham Thomas on Avandia Vote

Loading player, please wait...

Recommended Videos

  • Info

  • Comments

July 14 (Bloomberg) -- Abraham Thomas, a member of a U.S. Food and Drug Administration advisory panel, talks with Bloomberg's Peter Cook about the panel's vote today to recommend GlaxoSmithKline Plc be allowed to continue selling its diabetes pill Avandia. Thomas was one of 12 FDA advisers who recommended Avandia be recalled because of heart risks. Seventeen of 32 advisers recommended new warnings or restrictions for Avandia. Three panel members said no changes were needed to the drug’s prescribing information. Thomas speaks on Bloomberg Television's "Taking Stock." (Source: Bloomberg)


BTV Channel Finder


ZIP is required for U.S. locations

Bloomberg Television in   change